share_log

Med-X Appoints Linker & Associates as Sales Representative to Spearhead Business Development for Thermal-Aid Division

Med-X Appoints Linker & Associates as Sales Representative to Spearhead Business Development for Thermal-Aid Division

Med-X 任命 Linker & Associates 为销售代表,牵头 Thermal-Aid 部门的业务发展
Accesswire ·  2022/09/06 08:35

Leading Consumer Products Broker to Target Tier-1 Healthcare Distributors and Pharmacies to Enhance Thermal-Aid's National Distribution Footprint

领先的消费品经纪公司瞄准一级医疗保健分销商和药店,以扩大热辅助公司在全国的分销足迹

LOS ANGELES, CA / ACCESSWIRE / September 6, 2022 / Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, today announced that it has appointed Linker & Associates, a leading consumer products broker, as a sales representative for the Company's fast-growing Thermal-Aid division.

加利福尼亚州洛杉矶/ACCESSWIRE/2022年9月6日/面向病虫害防治、健康和保健市场的全天然绿色场景解决方案的领先创新者Med-X公司今天宣布,它已任命领先的消费品经纪公司Linker&Associates为公司快速增长的热辅助部门的销售代表。

Linker & Associates, led by President Brian Linker, brings over 20 years of consumer products broker experience working with several successful brands within the healthcare distribution space. Per the terms of the agreement, Linker & Associates will seek out prospective wholesale purchasers to enhance the national distribution footprint of Med-X's Thermal-Aid division, particularly within the healthcare and pharmacy space.

由总裁·布莱恩·林克领导的Linker&Associates拥有20多年在医疗保健分销领域与多个成功品牌合作的消费品经纪人经验。根据协议条款,Linker&Associates将寻找潜在的批发采购商,以加强Med-X热辅助部门的全国分销足迹,特别是在医疗保健和制药领域。

Med-X's popular Thermal-Aid line of pain management solutions are clinically proven, registered and trusted - specifically designed to reduce swelling and relieve various pain conditions - covering a wide variety of needs for adults, children and pets. Hand washable and mold resistant using a proprietary all-natural corn product as the heating and cooling element within the product line, Thermal-Aid stands alone in its category with consistent five-star reviews on Amazon Prime.

Med-X广受欢迎的热辅助系列疼痛管理解决方案经过临床验证、注册和信赖-专门设计用于减少肿胀和缓解各种疼痛状况-涵盖成人、儿童和宠物的各种需求。使用专有的全天然玉米产品作为产品线中的加热和冷却元件,可手工洗涤和防霉变,热辅助在同类产品中独树一帜,在Amazon Prime上获得一致的五星级评价。

"Brian and his team at Linker & Associates are well positioned in the U.S. healthcare products market to identify and support exciting new commercial opportunities for Thermal-Aid," said Jennifer Mills, President of Med-X. "We believe Brian's extensive relationships in the consumer products industry, longstanding industry experience and robust sales capabilities will provide an immediate impact on the sales and distribution of Thermal-Aid products. Acting like an extension of our in-house sales team, Brian will provide additional reach into healthcare and pharmacy wholesalers which we believe will generate the most lucrative incremental sales opportunities for our shareholders, building upon what is already a record year for our family of brands."

Med-X的詹妮弗·米尔斯说:“布赖恩和他在Linker&Associates的团队在美国保健产品市场处于有利地位,能够发现和支持热能援助的令人兴奋的新商业机会。我们相信,Brian在消费品行业的广泛关系、长期的行业经验和强大的销售能力将对热辅助产品的销售和分销产生立竿见影的影响。Brian将像我们内部销售团队的延伸一样,向医疗保健和药品批发商提供更多的触角,我们相信这将为我们的股东带来最有利可图的销售机会,在我们的品牌家族已经创纪录的一年的基础上再接再厉。“

Brian Linker added: "Med-X's Thermal-Aid product line brings incredible innovation to a long-tired category - acting not only as a hot and cold pack - but as an accessory with re-buy potential, turning a medical product into something adults and their children actually want to use. From initial reactions to samples I've seen, Med-X is onto something truly special with Thermal-Aid. I look forward to working closely with the Med-X team to introduce these incredible products to leading healthcare distributors nationally."

布莱恩·林克补充道:“Med-X的热辅助产品线为这个长期疲惫的产品类别带来了令人难以置信的创新--不仅充当冷热包装--而且是一种具有再购买潜力的配件,将医疗产品变成成人和他们的孩子真正想要使用的东西。从我看到的样品的初步反应来看,Med-X发现了一些真正特别的热辅助产品。我期待着与Med-X团队密切合作,将这些令人难以置信的产品介绍给全国领先的医疗分销商。”

About Med-X, Inc.

关于Med-X公司

Med-X, Inc. is a leading innovator of all-natural green scene solutions addressing the international pest control, health and wellness markets. Capitalizing on its diverse family of in-house brands to offer safe alternatives to conventional chemical and pharmaceutical products using all-natural ingredients, Med-X's comprehensive go-to-market strategy includes an integrated e-commerce, brick and mortar distributor and on-site services presence in key national markets. For more information, please visit .

Med-X,Inc.是面向国际病虫害防治、健康和保健市场的全天然绿色场景解决方案的领先创新者。Med-X利用其多样化的自有品牌系列,提供使用全天然成分的传统化学和医药产品的安全替代品,其全面的市场进入战略包括在关键的国家市场提供集成的电子商务、实体经销商和现场服务。欲了解更多信息,请访问。

Disclaimer and Forward-Looking Statements

免责声明和前瞻性声明

The securities offered by Med-X, Inc. hereby are highly speculative. Investing in shares of MED-X, INC. involves significant risk. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if and when a public market develops following this offering it may not continue. You should read the Regulation A+ Offering Circular Securities and Exchange Commission filings before making any investment in the Company. This press release may contain forward-looking statements regarding projected business performance, operating results, financial condition, and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The Company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.

Med-X,Inc.在此提供的证券具有很高的投机性。投资MED-X公司的股票。有很大的风险。这项投资只适用于那些能够承受全部投资损失的人。此外,投资者必须明白,一项投资可能在无限期内缺乏流动性。这些证券目前不存在公开市场,如果公开市场在此次发行后发展起来,它可能不会继续下去。在对该公司进行任何投资之前,您应阅读法规A+发售通函提交给美国证券交易委员会的文件。本新闻稿可能包含有关公司的预期业务业绩、经营结果、财务状况和其他方面的前瞻性陈述,用“预期”、“预期”、“预计”和“预测”等语言表达。请注意,此类陈述仅为估计,不能保证前瞻性陈述所陈述或暗示的结果将由公司实际实现。前瞻性陈述可能是基于被证明是错误的管理假设。本公司及其业务受到重大风险和非其控制的潜在事件的影响,这些风险和潜在事件将导致预期结果与实际结果之间存在重大差异,包括公司发生运营亏损和经历意外的重大不利事件。

Investor Relations Contact

投资者关系联系人

Lucas Zimmerman
Director
MZ Group - MZ North America
949-259-4987
MXRX@mzgroup.us

卢卡斯·齐默尔曼
董事
MZ集团-MZ北美
949-259-4987
邮箱:mxrx@mzgroup.us

SOURCE: Med-X, Inc.

资料来源:Med-X公司

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发